Janux Therapeutics, Inc. (JANX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Show:
Annual
Income Statement
All numbers in thousandsBreakdown
ttm
2020-12-31
2019-12-31
Total Revenue
2,021
0
0
Operating Expenses
Research Development
16,053
3,041
2,999
Selling General and Administrative
7,062
1,802
772
Total Operating Expenses
23,115
4,843
3,771
Operating Income or Loss
-21,094
-4,843
-3,771
Interest Expense
0
206
233
Total Other Income/Expenses Net
-
-1,735
-
Income Before Tax
-20,911
-6,784
-4,004
Income from Continuing Operations
-20,911
-6,784
-4,004
Net Income
-20,911
-6,784
-4,004
Net Income available to common shareholders
-20,911
-6,784
-4,004
Basic EPS
-
-1.06
-0.62
Diluted EPS
-
-1.06
-0.62
Basic Average Shares
-
6,415
6,415
Diluted Average Shares
-
6,415
6,415
EBITDA
-
-6,565
-3,765
